BIOMARIN PHARMACEUTICAL INC.

BMRN · NASDAQ

Pharmaceutical Preparation Manufacturing

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

ESG Scores

Overall ESG

4.3

Environmental

5.6

Social

3.6

Governance

5.1

Gender Diversity

Female Directors0.2727%

Female Executives0.0746268656716418%

Women in Workforce0.5%

CEO GenderMale

Market Data

Price$56.44+1.77 (+3.24%)

Market Cap$10.84B

P/E Ratio148.54

EPS$—

52W High$70.98

52W Low$49.26

Beta0.23